Levi & Korsinsky Urges Primo Brands Corporation / Primo Water Corporation (PRMB) Shareholders to Act Before Lead Plaintiff Deadline January 12, 2026
New York, New York--(Newsfile Corp. - November 14, 2025) - If you suffered a loss on your Primo Brands Corporation / Primo Water Corporation (NYSE: PRMB) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/primo-brands-corporation-primo-water-corporation-lawsuit-submission-form?prid=177497&wire=5&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call...
2025-11-14 3:55 PM EST
SNPS LAWSUIT ALERT: Levi & Korsinsky Notifies Synopsys, Inc. Investors - Lead Plaintiff Deadline December 30, 2025
New York, New York--(Newsfile Corp. - November 14, 2025) - If you suffered a loss on your Synopsys, Inc. (NASDAQ: SNPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/synopsys-inc-lawsuit-submission-form?prid=177496&wire=5&utm_campaign=7 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-11-14 3:38 PM EST
Lost Money on MoonLake Immunotherapeutics (MLTX)? Join Class Action Before December 15, 2025 - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - November 14, 2025) - If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ: MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=177495&wire=5&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced...
2025-11-14 3:35 PM EST
LRN ACTIVE INVESTIGATION: Lost Money on Stride, Inc.? Contact Levi & Korsinsky Now
New York, New York--(Newsfile Corp. - November 14, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Stride, Inc. ("Stride, Inc.") (NYSE: LRN) concerning possible violations of federal securities laws. On October 28, 2025, Stride reported its first quarter fiscal 2026 earnings after market. While earnings beat expectations, enrollment numbers and forward looking guidance fell significantly below expectations. While Stride has made investments in upgrading...
2025-11-14 3:30 PM EST
December 23, 2025 Deadline: Join Class Action Lawsuit Against James Hardie Industries plc. (JHX) - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - November 14, 2025) - If you suffered a loss on your James Hardie Industries plc. (NYSE: JHX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/james-hardie-industries-plc-lawsuit-submission-form?prid=177493&wire=5&utm_campaign=6 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of...
2025-11-14 3:25 PM EST
Recover Investment Losses: Class Action Initiated Against Inspire Medical Systems, Inc. (INSP)
New York, New York--(Newsfile Corp. - November 14, 2025) - If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE: INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=177492&wire=5&utm_campaign=24 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of...
2025-11-14 3:22 PM EST
KMX ALERT: Securities Fraud Class Action Launched Against CarMax, Inc. - January 2, 2026 Deadline
New York, New York--(Newsfile Corp. - November 14, 2025) - If you suffered a loss on your CarMax, Inc. (NYSE: KMX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/carmax-inc-lawsuit-submission-form?prid=177491&wire=5&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-11-14 3:18 PM EST
Ongoing Investigation into Molina Healthcare, Inc. (MOH): Contact Levi & Korsinsky About Potential Fraud
New York, New York--(Newsfile Corp. - November 14, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE: MOH) concerning possible violations of federal securities laws. On October 23, 2025, Molina published its third quarter, fiscal 2025 earnings well below consensus and slashed its guidance for the third time this year, citing cost pressure and underperformance. The Company is now expecting earnings of...
2025-11-14 8:47 AM EST
December 29, 2025 Deadline Approaching: Join Class Action Against Avantor, Inc. (AVTR) - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your Avantor, Inc. (NYSE: AVTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avantor-inc-lawsuit-submission-form?prid=177271&wire=5&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-11-13 4:58 PM EST
Investors in Tvardi Therapeutics, Inc. (TVRD) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today
New York, New York--(Newsfile Corp. - November 13, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Tvardi Therapeutics, Inc. ("Tvardi Therapeutics, Inc.") (NASDAQ: TVRD) concerning possible violations of federal securities laws. On October 13, 2025, Tvardi reported data from its Phase 2 REVERT study testing its STAT3 inhibitor drug, TTI-101, to treat patients with idiopathic pulmonary fibrosis (IPF). The company reported that "the study did not meet its...
2025-11-13 4:56 PM EST
Securities Lawsuit Alert: KBR, Inc. (KBR) - Contact Levi & Korsinsky Before November 18, 2025
New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your KBR, Inc. (NYSE: KBR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kbr-inc-lawsuit-submission-form?prid=177269&wire=5&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-11-13 3:47 PM EST
Class Action Alert: Levi & Korsinsky Reminds DexCom, Inc. (DXCM) Investors of December 26, 2025 Deadline
New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your DexCom, Inc. (NASDAQ: DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dexcom-inc-lawsuit-submission-form-2?prid=177268&wire=5&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-11-13 3:44 PM EST
Did You Suffer Losses in Perrigo Company plc (PRGO)? Contact Levi & Korsinsky About Securities Fraud Claims
New York, New York--(Newsfile Corp. - November 13, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Perrigo Company plc ("Perrigo Company plc") (NYSE: PRGO) concerning possible violations of federal securities laws. Perrigo issued a press release on November 5, 2025, "announc[ing] that it is initiating a strategic review of its infant formula business" which "will assess a range of alternatives." Perrigo said that the review "will focus on a combination of...
2025-11-13 3:32 PM EST
Securities Lawsuit Alert: Cytokinetics, Incorporated (CYTK) Investors - Contact Levi & Korsinsky Before November 17, 2025
New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ: CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=177266&wire=5&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of...
2025-11-13 3:19 PM EST
ALVO ALERT: Levi & Korsinsky Investigates Alvotech for Possible Securities Fraud Violations
New York, New York--(Newsfile Corp. - November 13, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Alvotech ("Alvotech") (NASDAQ: ALVO) concerning possible violations of federal securities laws. On November 2, 2025, Alvotech published a press release notifying investors that the Company received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for its Biologics License Application (BLA) for ATV05. The CRL noted that...
2025-11-13 9:25 AM EST
Investors Urged to Contact Levi & Korsinsky for Information Before January 5, 2026 - Inspire Medical Systems, Inc. (INSP)
New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE: INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=177137&wire=5&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of...
2025-11-13 9:05 AM EST
LRN Investor Notice: Levi & Korsinsky Investigates Stride, Inc. for Securities Law Violations
New York, New York--(Newsfile Corp. - November 13, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Stride, Inc. ("Stride, Inc.") (NYSE: LRN) concerning possible violations of federal securities laws. On October 28, 2025, Stride reported its first quarter fiscal 2026 earnings after market. While earnings beat expectations, enrollment numbers and forward-looking guidance fell significantly below expectations. While Stride has made investments in upgrading...
2025-11-13 8:56 AM EST
Class Action Lawsuit Filed: Baxter International, Inc. (BAX) - Join by December 15, 2025 - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - November 13, 2025) - If you suffered a loss on your Baxter International, Inc. (NYSE: BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=177135&wire=5&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of...
2025-11-13 8:19 AM EST
Lost Money on Synopsys, Inc. (SNPS)? Join Class Action Before December 30, 2025 - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - November 12, 2025) - If you suffered a loss on your Synopsys, Inc. (NASDAQ: SNPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/synopsys-inc-lawsuit-submission-form?prid=177030&wire=5&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder...
2025-11-12 4:56 PM EST
Join Class Action to Recover Losses from WPP plc (WPP) - Contact Levi & Korsinsky Before December 8, 2025
New York, New York--(Newsfile Corp. - November 12, 2025) - If you suffered a loss on your WPP plc (NYSE: WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wpp-plc-lawsuit-submission-form?prid=177028&wire=5&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-11-12 4:55 PM EST